NervGen Pharma Corp. - Common stock (NQ:NGEN)

4.210 +0.030 (+0.72%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist

Price and Volume

Volume	154,141
Open	4.170
Bid (Size)	4.160 (1,200)
Ask (Size)	4.220 (600)
Prev. Close	4.180
Today's Range	4.140 - 4.340
52wk Range	3.510 - 6.300
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

April 07, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates

March 31, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

Performance

YTD	-29.5%	-29.5%
1 Month	+1.4%	+1.4%
3 Month	-29.5%	-29.5%
6 Month	-29.5%	-29.5%
1 Year	-29.5%	-29.5%

More News

NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

March 12, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

March 04, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma to Participate at Upcoming Investor Conferences

February 18, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams

February 12, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium

February 11, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury

February 09, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing

January 20, 2026

From NervGen Pharma Corp.

Via GlobeNewswire

Frequently Asked Questions

Is NervGen Pharma Corp. - Common stock publicly traded?

Yes, NervGen Pharma Corp. - Common stock is publicly traded.

What exchange does NervGen Pharma Corp. - Common stock trade on?

NervGen Pharma Corp. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for NervGen Pharma Corp. - Common stock?

The ticker symbol for NervGen Pharma Corp. - Common stock is NGEN on the Nasdaq Stock Market

What is the current price of NervGen Pharma Corp. - Common stock?

The current price of NervGen Pharma Corp. - Common stock is 4.210

When was NervGen Pharma Corp. - Common stock last traded?

The last trade of NervGen Pharma Corp. - Common stock was at 04/09/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.